Andriy Sirko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andriy Sirko has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Lyudmila Dzyak
Dnipro State Medical University, Dnipro, Ukraine
11 shared publications - Dmytro M. Romanukha
Dnipropetrovsk Medical Academy, Dnipro
10 shared publications - Vadym Perepelytsia
Endovascular Center, Mechnikov Dnipropetrovsk Regional Clinical Hospital, Dnipro
10 shared publications - Rocco Anthony Armonda
Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, District of Columbia, USA
7 shared publications L. A. Dzyak
6 shared publicationsN. A. Zorin
Dnepropetrovsk State Medical Academy, Dnepropetrovsk
5 shared publications
Latest Publications
- 8 October 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Commentary: The Modified Sparing Binostril Endoscopic Endonasal Approach Combined With an Algorithm-Based Reconstruction Strategy: Surgical and Functional Outcomes in Sellar and Suprasellar Lesions
Was not provided for this article.
- 8 October 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Commentary: The Modified Sparing Binostril Endoscopic Endonasal Approach Combined With an Algorithm-Based Reconstruction Strategy: Surgical and Functional Outcomes in Sellar and Suprasellar Lesions
Was not provided for this article.
- 31 August 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (10) , 3074-3091
Explosive Weapons Trauma Care Collective (EXTRACCT) Blast Injury Clinical Practice Guideline: Traumatic Brain Injury From Blast and Penetrating Mechanisms in Settings With Variable Resource Availability
Introduction: Blast‐ and penetrating‐mechanism traumatic brain injury (TBI) is increasingly prevalent in settings affected by conflict and explosive violence, including among local casualties in environments where neurosurgical infrastructure, advanced imaging, and critical care resources may be limited or absent. No protocols or guidelines comprehensively address the full spectrum of TBI from blast and penetrating mechanisms across variable resource levels. Methods: The Explosive Weapons Trauma Care Collective (EXTRACCT) conducted a targeted narrative literature review across key clinical domains, including initial assessment, hemodynamic and airway management, medical treatment of intracranial hypertension, noninvasive neuromonitoring, surgical decision‐making, and interfacility transport. Searches were performed in PubMed and supplemented by military, penetrating and trauma system clinical practice guidelines (Joint Trauma System, Brain Trauma Foundation, TCCC). Evidence was synthesized by a multidisciplinary authorship team and consensus was achieved through iterative expert review, following the AGREE II framework. Results: This document provides stratified recommendations across variable resource contexts. Key recommendations include: early physiological stabilization with avoidance of hypotension and hypoxia; structured neurological assessment using postresuscitation GCS and pupillometry; noncontrast head CT as the primary imaging modality, with CT angiography for penetrating TBI and high‐risk blunt mechanisms; hyperosmolar therapy as first‐line treatment for intracranial hypertension; evidence‐based sedation, analgesia, and neuromuscular blockade protocols; noninvasive multimodal neuromonitoring when invasive ICP monitoring is unavailable; surgical thresholds for decompressive craniectomy and craniotomy; and standardized transport protocols to minimize secondary brain injury during interfacility transfer. Conclusions: This document addresses a critical gap in context‐appropriate blast‐TBI management for settings with variable resource availability. Strict control of basic physiological parameters, structured clinical decision‐making, and early transfer to neurosurgical care remain the primary determinants of outcome in resource‐limited environments.
- 31 August 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (10) , 3074-3091
Explosive Weapons Trauma Care Collective (EXTRACCT) Blast Injury Clinical Practice Guideline: Traumatic Brain Injury From Blast and Penetrating Mechanisms in Settings With Variable Resource Availability
Introduction: Blast‐ and penetrating‐mechanism traumatic brain injury (TBI) is increasingly prevalent in settings affected by conflict and explosive violence, including among local casualties in environments where neurosurgical infrastructure, advanced imaging, and critical care resources may be limited or absent. No protocols or guidelines comprehensively address the full spectrum of TBI from blast and penetrating mechanisms across variable resource levels. Methods: The Explosive Weapons Trauma Care Collective (EXTRACCT) conducted a targeted narrative literature review across key clinical domains, including initial assessment, hemodynamic and airway management, medical treatment of intracranial hypertension, noninvasive neuromonitoring, surgical decision‐making, and interfacility transport. Searches were performed in PubMed and supplemented by military, penetrating and trauma system clinical practice guidelines (Joint Trauma System, Brain Trauma Foundation, TCCC). Evidence was synthesized by a multidisciplinary authorship team and consensus was achieved through iterative expert review, following the AGREE II framework. Results: This document provides stratified recommendations across variable resource contexts. Key recommendations include: early physiological stabilization with avoidance of hypotension and hypoxia; structured neurological assessment using postresuscitation GCS and pupillometry; noncontrast head CT as the primary imaging modality, with CT angiography for penetrating TBI and high‐risk blunt mechanisms; hyperosmolar therapy as first‐line treatment for intracranial hypertension; evidence‐based sedation, analgesia, and neuromuscular blockade protocols; noninvasive multimodal neuromonitoring when invasive ICP monitoring is unavailable; surgical thresholds for decompressive craniectomy and craniotomy; and standardized transport protocols to minimize secondary brain injury during interfacility transfer. Conclusions: This document addresses a critical gap in context‐appropriate blast‐TBI management for settings with variable resource availability. Strict control of basic physiological parameters, structured clinical decision‐making, and early transfer to neurosurgical care remain the primary determinants of outcome in resource‐limited environments.
- 17 July 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Commentary: Endoscopic Epidural Anterior Transpetrosal Approach (Endoscopic Kawase's Approach) for Meningiomas Around the Petrous Apex
Was not provided for this article.
- 17 July 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Commentary: Endoscopic Epidural Anterior Transpetrosal Approach (Endoscopic Kawase's Approach) for Meningiomas Around the Petrous Apex
Was not provided for this article.
- 6 July 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Commentary: The Feasibility of Neuroendoscopic Fenestration in Septated Chronic Subdural Hematoma
Was not provided for this article.
- 6 July 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Commentary: The Feasibility of Neuroendoscopic Fenestration in Septated Chronic Subdural Hematoma
Was not provided for this article.
- Open Access
- 29 March 2026
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 32 (1) , 24-39
Endovascular treatment of chronic subdural hematomas
Objective: To evaluate the effectiveness of middle meningeal artery embolization (MMAe) in patients with chronic subdural hematoma (cSDH) based on the first 19 clinical cases performed at Mechnikov Dnipropetrovsk Regional Clinical Hospital. To clarify the indications for isolated versus combined treatment of cSDH and to assess the feasibility of the transradial approach. Materials and methods: A retrospective cohort study was conducted based on the analysis of prospectively collected data from patients with chronic subdural hematomas who underwent MMAe at I.I. Mechnikov Dnipropetrovsk Regional Clinical Hospital between March 24, 2022, and November 6, 2024. The study included 19 patients who underwent endovascular intervention, either as a standalone procedure or in combination with open surgery. Demographic data, etiological factors, clinical presentation, CT, MRI, and DSA findings were analyzed. Treatment effectiveness was assessed at 1, 3, and 6 months postoperatively. Results: According to the type of treatment, patients were divided into 3 groups: isolated MMAe — 13 patients (68.4%); primary MMAe followed by surgical drainage — 3 patients (15.8%); primary surgical evacuation followed by MMAE — 3 patients (15.8%). Traumatic cSDH was diagnosed in 12 patients (63.2%), while spontaneous cSDH occurred in 7 patients (36.8%), including two cases with mycotic aneurysms of cortical Middle Cerebral Artery (MCA) branches, which were managed with endovascular deconstructive exclusion and subsequent MMAe. One patient with chronic anemia underwent isolated MMAe. Among all patients, 5 (26.3%) were on anticoagulant/antiplatelet therapy, and hemodynamically significant carotid stenosis was identified in 3 patients (15.8%). Follow-up imaging (CT, MRI) at 6 months demonstrated clinical improvement in 100% of cases, with complete hematoma resolution in 17 patients (89.5%). Conclusions: MMAe has proven to be highly effective and safe in the management of cSDH, both as a stand-alone method and as an adjunct to conventional surgery. The transradial approach demonstrated advantages in elderly and high-risk patients, contributing to reduced hospitalization times. Furthermore, the use of OnyxTM ensured deeper penetration and more durable occlusion of pathological vessels compared to polyvinyl alcohol (PVA) particles. These findings are consistent with current global trends and confirm the promising role of MMAe in cSDH treatment.
- 29 March 2026
- Published by Romodanov Neurosurgery Institute in Ukrainian Neurosurgical Journal
- Vol. 32 (1) , 24-39
Open AccessEndovascular treatment of chronic subdural hematomas
Objective: To evaluate the effectiveness of middle meningeal artery embolization (MMAe) in patients with chronic subdural hematoma (cSDH) based on the first 19 clinical cases performed at Mechnikov Dnipropetrovsk Regional Clinical Hospital. To clarify the indications for isolated versus combined treatment of cSDH and to assess the feasibility of the transradial approach. Materials and methods: A retrospective cohort study was conducted based on the analysis of prospectively collected data from patients with chronic subdural hematomas who underwent MMAe at I.I. Mechnikov Dnipropetrovsk Regional Clinical Hospital between March 24, 2022, and November 6, 2024. The study included 19 patients who underwent endovascular intervention, either as a standalone procedure or in combination with open surgery. Demographic data, etiological factors, clinical presentation, CT, MRI, and DSA findings were analyzed. Treatment effectiveness was assessed at 1, 3, and 6 months postoperatively. Results: According to the type of treatment, patients were divided into 3 groups: isolated MMAe — 13 patients (68.4%); primary MMAe followed by surgical drainage — 3 patients (15.8%); primary surgical evacuation followed by MMAE — 3 patients (15.8%). Traumatic cSDH was diagnosed in 12 patients (63.2%), while spontaneous cSDH occurred in 7 patients (36.8%), including two cases with mycotic aneurysms of cortical Middle Cerebral Artery (MCA) branches, which were managed with endovascular deconstructive exclusion and subsequent MMAe. One patient with chronic anemia underwent isolated MMAe. Among all patients, 5 (26.3%) were on anticoagulant/antiplatelet therapy, and hemodynamically significant carotid stenosis was identified in 3 patients (15.8%). Follow-up imaging (CT, MRI) at 6 months demonstrated clinical improvement in 100% of cases, with complete hematoma resolution in 17 patients (89.5%). Conclusions: MMAe has proven to be highly effective and safe in the management of cSDH, both as a stand-alone method and as an adjunct to conventional surgery. The transradial approach demonstrated advantages in elderly and high-risk patients, contributing to reduced hospitalization times. Furthermore, the use of OnyxTM ensured deeper penetration and more durable occlusion of pathological vessels compared to polyvinyl alcohol (PVA) particles. These findings are consistent with current global trends and confirm the promising role of MMAe in cSDH treatment.
- Open Access
- 1 March 2026
- Published by AME Publishing Company in AME Case Reports
- Vol. 10, 67
Endovascular management of craniospinal arteriovenous fistula causing steal syndrome in neurofibromatosis type 1: a case report
Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder. It primarily involves cutaneous, neurological and skeletal systems, with vascular involvement being relatively uncommon. Among the reported vascular manifestations, stenoses, aneurysms, and arteriovenous fistulas (AVFs) are infrequent but potentially serious complications. Their manifestation with cerebral steal syndrome is of even lower prevalence. Case Description: We report a case of a 52-year-old female with known NF1 who presented with progressive headache, transient episodes of right-sided weakness and speech problems. Total selective digital subtractive cerebral angiography revealed AVF of the left occipital region, primarily supplied by a large longitudinal defect in the V4 segment of the left vertebral artery, with additional feeders from the left occipital and ascending cervical arteries. A vertebrobasilar “steal” phenomenon was observed, with retrograde filling of the basilar circulation via the carotid system. Given the progressive symptoms and hemodynamic compromise, the patient underwent endovascular embolization using balloon catheters, detachable coils and Onyx 18 liquid embolic agent. The procedure was uneventful, with successful devascularization of the AVF and improved perfusion to the surrounding tissue. Post procedural recovery was favorable, with disappearing of existed symptoms. Conclusions: AVFs are rare in patients with NF1, and their pathogenesis is not fully understood. Steal syndrome occurs when high flow vascular malformations divert blood from surrounding brain parenchyma, leading to ischemic symptoms. Our case contributes to the limited literature on NF1-associated AVF and supports early neurovascular imaging in symptomatic individuals. Awareness of this rare vascular complication in NF1 is crucial for timely diagnosis and management.
- 1 March 2026
- Published by AME Publishing Company in AME Case Reports
- Vol. 10, 67
Open AccessEndovascular management of craniospinal arteriovenous fistula causing steal syndrome in neurofibromatosis type 1: a case report
Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder. It primarily involves cutaneous, neurological and skeletal systems, with vascular involvement being relatively uncommon. Among the reported vascular manifestations, stenoses, aneurysms, and arteriovenous fistulas (AVFs) are infrequent but potentially serious complications. Their manifestation with cerebral steal syndrome is of even lower prevalence. Case Description: We report a case of a 52-year-old female with known NF1 who presented with progressive headache, transient episodes of right-sided weakness and speech problems. Total selective digital subtractive cerebral angiography revealed AVF of the left occipital region, primarily supplied by a large longitudinal defect in the V4 segment of the left vertebral artery, with additional feeders from the left occipital and ascending cervical arteries. A vertebrobasilar “steal” phenomenon was observed, with retrograde filling of the basilar circulation via the carotid system. Given the progressive symptoms and hemodynamic compromise, the patient underwent endovascular embolization using balloon catheters, detachable coils and Onyx 18 liquid embolic agent. The procedure was uneventful, with successful devascularization of the AVF and improved perfusion to the surrounding tissue. Post procedural recovery was favorable, with disappearing of existed symptoms. Conclusions: AVFs are rare in patients with NF1, and their pathogenesis is not fully understood. Steal syndrome occurs when high flow vascular malformations divert blood from surrounding brain parenchyma, leading to ischemic symptoms. Our case contributes to the limited literature on NF1-associated AVF and supports early neurovascular imaging in symptomatic individuals. Awareness of this rare vascular complication in NF1 is crucial for timely diagnosis and management.